| Particulars |
| Company Name |
Natco Pharma Ltd |
| Face Value |
2 |
| BSE Code |
524816 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
35.82 |
| B.V. Rs |
461.80 |
| Sales Rs in Cr. |
4,094.50 |
| NP Rs in Cr. |
1,778.18 |
| NP Var% |
36.00 |
| Div% |
300.00 |
| CPS Rs |
111.60 |
| EPS Rs |
99.30 |
| Traded Value(Rs in Lakhs) |
683.78 |
| 52 Week High |
1,060.00 |
| 52 Week Low |
660.00 |
| Price BSE |
822.00 |
| Price NSE |
824.00 |
| Market Capital(Rs in Cr.) |
14,724.62 |
| P/C Ratio |
7.40 |
| P/E Ratio |
8.30 |
| Price Vs.BV |
1.78 |
| Latest Quarter |
| Year End |
202512 |
| Sales Rs in Cr. |
528.80 |
| NP Rs in Cr. |
106.90 |
| NP Var % |
-14.00 |
| Trailing Twelve Months |
| Year End |
202512 |
| Sales |
4,119.60 |
| OPM |
54.49 |
| NP |
1,838.50 |
| NP Var% |
-15.32 |
| EPS |
83.75 |
| PE |
9.82 |
|